Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Cerny MA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Černý Matej
Publikováno v:
SHS Web of Conferences, Vol 83, p 01008 (2020)
This paper is focused on the issue, how the business can analyze all data types (structured and unstructured) in one cooperative environment. With structured data handle Business Intelligence and with unstructured data on the other side Big Data. As
Externí odkaz:
https://doaj.org/article/b0e4501795b042c99f6050b01383e507
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Filipski KJ; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Martinez-Alsina LA; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Reese MR; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Evrard E; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Buzon LM; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Cameron KO; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Zhang Y; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Coffman KJ; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Bradow J; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Kormos BL; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Liu S; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Knafels JD; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Sahasrabudhe PV; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Chen J; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Kalgutkar AS; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Bessire AJ; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Orozco CC; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Balesano A; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Cerny MA; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Bollinger E; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Reyes AR; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Laforest B; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Rosado A; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Williams G; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Marshall M; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Tam Neale K; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Chen X; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Hirenallur-Shanthappa D; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Stansfield JC; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Groarke J; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Qiu R; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Karas S; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Roth Flach RJ; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Esler WP; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.
Autor:
Savaryn JP; AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA. john.savaryn@abbvie.com., Coe K; J&J, Translational PKPD & Investigational Toxicology, San Diego, CA, USA., Cerny MA; Pfizer, Inc, Groton, CT, USA., Colizza K; GSK, DMPK Disposition and Biotransformation, Collegeville, PA, USA. kevin.x.colizza@gsk.com., Moliner P; Sanofi, Montpellier, France., King L; UCB Biopharma, Dept. of DMPK, Slough, UK., Ma B; Genentech, Inc., Department of Drug Metabolism and Pharmacokinetics, South San Francisco, CA, USA., Atherton J; Incyte Research Institute, Translational Sciences, Wilmington, DE, USA., Auclair A; Boehringer Ingelheim Pharmaceuticals, Inc.,Drug Metabolism and Pharmacokinetics, Ridgefield, CT, USA., Cancilla MT; Merck & Co., Inc., Pharmacokinetics, Dynamics, Metabolism, and Bioanalysis, Rahway, NJ, USA., Eno M; Eisai Inc., Global Drug Metabolism and Pharmacokinetics, Cambridge, MA, USA., Jurva U; AstraZeneca, Drug Metabolism and Pharmacokinetics (DMPK), Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, Gothenburg, Sweden., Yue Q; Gilead Sciences, Inc., Drug Metabolism Dept, Foster City, CA, USA., Zhu SX; Takeda Development Center Americas, Inc., Drug Metabolism and Pharmacokinetics & Modeling, Cambridge, MA, USA., Freiberger E; AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA., Zhong G; Amgen, Pharmacokinetics and Drug Metabolism Department, South San Francisco, CA, USA., Barlock B; Blueprint Medicines, Cambridge, MA, USA., Nachtigall J; Merck Healthcare KGaA, Department NCE DMPK, Darmstadt, Germany., Laboureur L; R&D Paris-Saclay Servier Institute, DMPK, Gif-Sur-Yvette, France., Pusalkar S; Servier Bioinnovation, LLC, DMPK, Boston, MA, USA., Guo R; Beigene, DMPK, Department of Biology, Shanghai, China., Niehues M; Bayer AG, In Vitro ADME & Isotope Chemistry, Berlin, Germany., Hauri S; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Carreras ET; Novartis Pharma AG, Novartis Institute for Biomedical Research, Basel, Switzerland., Maurer C; Merck Healthcare KGaA, Department NCE DMPK, Darmstadt, Germany., Prakash C; DMPK/Clinical Pharmacology, Agios Pharmaceuticals, Cambridge, MA, USA., Jenkins GJ; AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.
Autor:
Bauman JN; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.) jonathan.bauman@pfizer.com., Doran AC; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Gualtieri GM; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Hee B; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Strelevitz T; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Cerny MA; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Banfield C; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Plotka A; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Wang X; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Purohit VS; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Dowty ME; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Sep 16; Vol. 52 (10), pp. 1124-1136. Date of Electronic Publication: 2024 Sep 16.
Autor:
Rodrigues D; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Niosi M; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Eng H; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Healy C; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Lazzaro S; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Yang Q; Computational Chemistry, Internal Medicine, Medicine Design, Worldwide Research & Development, Cambridge, Massachusetts, USA., Cerny MA; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2023 Aug; Vol. 63 (8), pp. 875-879. Date of Electronic Publication: 2023 Apr 27.
Autor:
Orozco CC; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Neuvonen M; Department of Clinical Pharmacology, University of Helsinki, Helsinki FI-00014, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki FI-00014, Finland., Bi YA; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Cerny MA; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Mathialagan S; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Tylaska L; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Rago B; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Costales C; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., King-Ahmad A; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Niemi M; Department of Clinical Pharmacology, University of Helsinki, Helsinki FI-00014, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki FI-00014, Finland.; Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki FI-00029, Finland., Rodrigues AD; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2023 Jun 05; Vol. 20 (6), pp. 3020-3032. Date of Electronic Publication: 2023 May 03.